Residents and their Preceptors
![](https://www.aphafoundation.org/sites/default/files/styles/paragraph_with_image/public/Lezina%202.jpg?itok=E2Gk5lAB)
Dru Lezina
Project Proposal: The Effect of a Slow Titration of Dimethyl Fumarate on Patient Adherence and Tolerability
Dru Lezina, PharmD currently serves as the PGY-1 Community Pharmacy Practice Resident at University of Southern California / Keck Medicine of USC Specialty Pharmacy in Los Angeles, California. Dr. Lezina graduated from Xavier University of Louisiana College of Pharmacy.
With this research project, she hopes to bridge the gap in knowledge regarding the appropriate dose titration of dimethyl fumarate. The purpose of a three-week slow titration is to alleviate patients adverse events in the beginning of therapy to increase patients drug tolerability and adherence.